Luxcia Kugathasan

16PUBLICATIONS
55CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cardiology (incl. cardiovascular diseases)Molecular targetsMedical biochemistry - amino acids and metabolitesNutrigenomics and personalised nutrition
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|Aug 27, 2026
Role of Omega-3 Fatty Acids in IgA Nephropathy: An Updated Review of Mechanisms and Evidence.

|Feb 26, 2026
Mechanisms of SGLT inhibitor action and physiological mediators: systematic review and protocol for the MOSAIC collaborative meta-analysis.

Luxcia Kugathasan, Massimo Nardone, Marcel H A Muskiet

|Dec 12, 2025
Efficacy, Mechanisms, and Safety of Sodium-Glucose Cotransporter-2 Inhibitors in Kidney Transplant Recipients: A Randomized, Double-Blind, Placebo-Controlled Trial.

Vikas S Sridhar, Luxcia Kugathasan, Yuliya Lytvyn

|Dec 05, 2025
Cardiovascular-Kidney Effects of Dapagliflozin in Patients at Cardiovascular Risk With or Without Type 2 Diabetes: Results of a Randomized, Double-Blind, Placebo-Controlled Trial.

Vikas S Sridhar, Luxcia Kugathasan, Yuliya Lytvyn

|Aug 22, 2025
Metabolic shifts in plasma amino acids and related metabolites in response to SGLT2 inhibition and hyperglycemia in type 1 diabetes.

Luxcia Kugathasan, Nagarjunachary Ragi, Subrata Debnath

|Jul 22, 2025
Advancing kidney protection in type 1 diabetes: insights from emerging therapies in type 2 diabetes and chronic kidney disease.

Luxcia Kugathasan, Yarden Aronson, Vikas S Sridhar

Pageof 3

Frequent Collaborators

7 joint publications

Vikas Srinivasan Sridhar

7 joint publications

David Z I Cherney

5 joint publications

Leif Erik Lovblom

3 joint publications

Alessandro Doria